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Abstract The function of selenoprotein W (Se-W) was inves-
tigated by cloning the corresponding cDNA from mouse brain
and expressing it in CHO cells and H1299 human lung cancer
cells. Overexpression of Se-W markedly reduced the sensitivity
of both cell lines to H2O2 cytotoxicity. The intracellular
peroxide concentration of the transfected cells was lower than
that of the parental cells in the absence or presence of
extracellular H2O2. The resistance to oxidative stress conferred
by Se-W was dependent on glutathione. Expression of Se-W
mutants in which selenocysteine-13 or cysteine-37 was replaced
by serine did not confer resistance to H2O2, implicating these
residues in the antioxidant activity of Se-W in vivo. ß 2002
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Reactive oxygen species (ROS) such as hydrogen peroxide
(H2O2), the superoxide anion radical (Oc32 ), and the hydroxyl
radical (OHc) are toxic by-products of cellular oxygen metab-
olism [1]. The intracellular concentration of ROS has been
implicated as a determinant of apoptosis, aging, cancer, and
cell cycle arrest [2,3]. The direct reduction of H2O2 by gluta-
thione peroxidase (GPx) and catalase as well as the scaveng-
ing of superoxide radicals by superoxide dismutase contribute
to homeostasis of the intracellular redox state [4^6].
Two selenoproteins, GPx and thioredoxin reductase, serve
to protect cells from oxidative stress. Whereas GPx catalyzes
the reduction of peroxides that might damage cells and tissues
[4], thioredoxin reductase provides reducing equivalents for
various biochemical processes and antioxidant defenses [7].
Selenoprotein P has also been proposed to function in extra-
cellular £uid as a glutathione-dependent peroxidase for phos-
pholipid hydroperoxides [8].
Selenoprotein W (Se-W) contains both a selenocysteine (Se-
Cys) residue that is encoded by a UGA codon in the open
reading frame of the mRNA as well as a bound glutathione
(GSH) molecule at residue Cys37 [9,10]. The protein is local-
ized predominantly in the cytoplasm, but a small proportion
of total Se-W is associated with the cell membrane [11,12].
Se-W was expressed in all tissues examined in selenium-sup-
plemented animals, including muscle, heart, testis, spleen, kid-
ney, intestine, tongue, brain, lung, and liver [10,13^15], and its
abundance in various tissues was increased by selenium sup-
plementation. Expression of Se-W in the brain was preserved
even under conditions of selenium de¢ciency [14]. Given the
presence of the bound GSH moiety, Se-W is thought to func-
tion in oxidation^reduction catalysis [16], and it may play a
role in selenium de¢ciency disorders such as white muscle
disease of sheep and Keshan disease in humans [12,17]. How-
ever, Se-W has not been shown directly to function as an
antioxidant.
To investigate the possible role of Se-W as a ROS scavenger
in vivo, we have isolated the corresponding cDNA from a
mouse brain library and expressed the encoded protein in
cell lines. We show that ectopic expression of Se-W renders
cells resistant to H2O2 and that this resistance is dependent on
GSH.
2. Materials and methods
2.1. Cell culture
Chinese hamster ovary (CHO) dhfr3 cells, which are de¢cient in
dihydrofolate reductase, were cultured in Ham’s F-12 nutrient me-
dium (Gibco-BRL) containing L-glutamine and 14 mM NaHCO3
and supplemented with 10% fetal bovine serum and antibiotics. Hu-
man lung cancer H1299 cells were cultured in RPMI 1640 medium
(Gibco-BRL) containing L-glutamine and 24 mM NaHCO3 and sup-
plemented with 5% fetal bovine serum and antibiotics. Both cell lines
were maintained at 37‡C under an atmosphere of 95% air and 5%
CO2 in a humidi¢ed incubator.
2.2. Cloning of the Se-W cDNA and construction of stable cell lines
The Se-W cDNA was cloned from a mouse brain cDNA library in
the Lambda ZAP II vector (Stratagene) by screening with a speci¢c
internal antisense oligonucleotide probe (5P-TCCACRTAGC-
CATCRCC-3P, where R indicates A or G; based on the sequences
of mouse and rat cDNAs) with the use of ECL 3P-oligonucleotide
labeling and detection systems (Amersham Pharmacia Biotech). The
isolated full-length cDNA was incorporated into the pBluescript SK3
plasmid by in vivo excision with helper phage (Stratagene). The
cDNA was con¢rmed by sequencing with an Applied Biosystems
model ABI 373A automated DNA sequencer (Pharmacia Biotech).
The DNA fragment (containing the cDNA) released by digestion of
the modi¢ed pBluescript SK3 plasmid with BamHI and XhoI was
then subcloned into the mammalian expression vector pcDNA3.1+
(Invitrogen), yielding pcDNA3.1+/selW.
The SeCys13 residue of Se-W was changed to Cys or Ser by site-
speci¢c mutagenesis of the cDNA with the use of the polymerase
chain reaction (PCR). The PCR primers for mutagenesis were 5P-
GCGGAATTCATGGCGCTCGCCGTTCGAGTCGTGTATTGTG-
GAGCTTGC(TCA)GGCTAT-3P (sense) and 5P-CCCTCTAGACAG-
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CAGAATCCATC-3P (antisense), in which the underlines indicate the
substituted Cys (or Ser) codon and the italics indicate EcoRI and
XbaI sites, respectively. The DNA fragments released by digestion
of the PCR products with EcoRI and XbaI were ligated with
pcDNA3.1+ that had been digested with the same restriction enzymes.
The resulting mutants were designated SeC13C and SeC13S, respec-
tively. Site-directed mutagenesis of Cys37 to Ser was also performed
with a Quickchange kit (Stratagene); the mutagenic synthetic primer
was 5P-GCCTGGACATTTCTGGCGAGGGGAC-3P, in which the
underline indicates the substituted Ser codon. The resulting mutant
was designated C37S.
Plasmids containing the wild-type or mutant Se-W cDNAs were
introduced into H1299 or CHO dhfr3 cells by transfection with the
use of Lipofectamine (Gibco-BRL), and the resulting stable cell lines
were selected by culture in the presence of 500 WM G418 (Gibco-BRL)
for 14 days.
2.3. Cell viability after H2O2 exposure
The viability of cells after exposure to H2O2 was determined on the
basis of trypan blue exclusion. Cells (2U105) were seeded on 60-mm
dishes and incubated for 24 h, after which the medium was replaced
and the cells were incubated for an additional 12 h before exposure to
H2O2. The numbers of viable and non-viable cells at various times
after exposure to H2O2 were counted with the use of a light micro-
scope, and the percentage of cells excluding trypan blue was taken as
an index of cell viability.
2.4. Depletion of GSH with BSO and measurement of total GSH
Cells (2U105) were incubated in 60-mm dishes for 24 h before
exposure to fresh medium containing 300 WM L-buthionine-[S,R]-sulf-
oxide (BSO), an inhibitor of de novo GSH synthesis, for 16 h. The
concentrations of both GSH and GSSG were determined by monitor-
ing spectrophotometrically the GSH-dependent formation of 5-thio-2-
nitrobenzoate from 5,5P-thiobis(2-nitrobenzoate) at 412 nm, as de-
scribed previously [18].
2.5. Preparation of a monoclonal antibody to Se-W
A monoclonal antibody to Se-W was prepared by immunizing mice
with puri¢ed Se-W (SeC13C mutant). Puri¢cation of Se-W was facili-
tated by fusing the protein to maltose-binding protein by ligation of a
DNA fragment containing the mutant cDNA with the expression
vector pMAL-cRI (New England Biolabs). The recombinant fusion
protein was expressed in Escherichia coli BL21 (DE3) and then puri-
¢ed with the use of an amylose resin (New England Biolabs). Six-
week-old male BALB/c mice were injected with 0.2 ml of a suspension
containing 50 Wg of antigen mixed with an equal volume of complete
Freund’s adjuvant. The mice were subsequently injected at 2-week
intervals with antigen mixed with incomplete Freund’s adjuvant or
antigen alone, respectively. Monoclonal antibodies speci¢c for Se-W
were then generated as described previously [19]. Ascitic £uid was
collected about 1 week after injection of hybridoma, and antibody
titer was determined by immunoblot analysis.
3. Results and discussion
3.1. Cloning of Se-W cDNA and construction of stable cell
lines overexpressing Se-W
The Se-W cDNA was cloned from mouse brain and se-
quenced (GenBank accession number AF241527). The
cDNA sequence is 100% identical to those previously deter-
mined for Se-W cDNAs isolated from mouse skeletal muscle,
mouse fetus, and rat skeletal muscle (GenBank accession
numbers U67890, AF015284, and U25264, respectively), and
includes a SeCys residue encoded by TGA at codon 13. The
cloned cDNA was introduced by transfection into H1299 and
CHO dhfr3 cells, and the resulting stable cell lines were des-
ignated H1299/selW and CHO dhfr3/selW, respectively.
The expression of the Se-W cDNA at the mRNA and pro-
tein levels was con¢rmed by reverse transcription-PCR anal-
ysis with speci¢c primers (Fig. 1A) and by the incorporation
of 75Se into a protein of V10 kDa (Fig. 1B), respectively. The
Se-W mRNA and protein were detected in stable transfectants
but not in the parental cells.
3.2. GSH-dependent resistance of transfected cells to H2O2
Preliminary studies revealed that H1299 cells were more
sensitive to H2O2 than were CHO dhfr3 cells. H1299 and
CHO cells were therefore exposed to 50 and 200 WM H2O2,
respectively, to investigate the e¡ect of Se-W overexpression
on sensitivity to this agent. The viability of stable transfec-
tants of either cell line after treatment with H2O2 was greater
than that of parental cells (Fig. 2A,B), indicating that expres-
sion of Se-W protects cells from oxidative damage induced by
H2O2.
To determine whether the GSH moiety that is bound to
Fig. 1. Expression of Se-W cDNA in stable transfectants. A: Re-
verse transcription-PCR analysis of Se-W mRNA. Analysis was
performed with primers speci¢c for Se-W cDNA (Oligo 1, 5P-
GGGGAATTCATGGCGCTCGCCGTT-3P ; Oligo 2, 5P-CCCTC-
TAGATGCCTCTAGGGTCA-3P) and for L-actin cDNA (oligo 1,
5P-GATGACGATATCGCTGCGCT-3P ; oligo, 2, 5P-GATCATT-
GCCGATAGTGATGACCT-3P). Lane 1, the PCR product of
pcDNA3.1+/selW (control) ; lane 2, CHO dhfr3 cells ; lane 3, CHO
dhfr3/selW cells. The positions of the PCR products derived from
L-actin cDNA and Se-W cDNA (312 bp) are indicated. B: Labeling
of Se-W with 75Se. H1299 (lane 1) and H1299/selW (lane 2) cells
were grown to 60% con£uence and then labeled with sodium
[75Se]selenite (2 WCi/ml; neutral pH) for 3 days. The cells were har-
vested, washed with phosphate-bu¡ered saline, and lysed by gentle
agitation in ice-cold RIPA bu¡er (50 mM Tris^HCl (pH 7.4), 1%
Nonidet P-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM
phenylmethylsulfonyl £uoride). Lysates were centrifuged at
12 000Ug, and the resulting supernatants (100 Wg of protein) were
fractionated by SDS^polyacrylamide gel electrophoresis through a
12% gel. The gel was then dried and analyzed with an imager (Fuji-
¢lm BAS-2500). Lane M, protein size markers (in kDa). Arrow in-
dicates the 10-kDa band corresponding to Se-W.
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Cys37 of Se-W [12,13] contributes to the observed antioxidant
activity of this protein, we pretreated cells for 16 h with 300
WM BSO, an inhibitor of Q-glutamylcysteinyl synthetase, the
¢rst enzyme in the GSH biosynthetic pathway [20]. During the
16-h incubation with BSO, the total GSH content of H1299
cells decreased from 38.52 þ 3.34 to 2.74 þ 0.40 nmol/mg
of protein and that of CHO dhfr3 cells declined from
30.32 þ 2.85 to 3.20 þ 0.51 nmol/mg. BSO treatment of stable
transfectants increased their sensitivity to H2O2 to levels similar
to those apparent for non-treated parental cells (Fig. 2C,D).
Consistent with previous observations [21], the sensitivity of
GSH-depleted parental cells to H2O2 was greater (by V20%)
than that of the corresponding GSH-replete cells. BSO treat-
ment alone did not a¡ect cell viability during subsequent in-
cubation of cells for 24 or 36 h in the absence of H2O2 (data
not shown).
The loss of the protective e¡ect of Se-W against H2O2-in-
duced cytotoxicity in cells treated with an inhibitor of GSH
synthesis indicates that Se-W is a GSH-dependent antioxidant
in vivo. GSH and its redox cycle play a critical role in catab-
olizing H2O2 and other peroxides through enzymatic coupling
reactions. Furthermore, GSH is important for the detoxi¢ca-
tion of electrophiles and for protection of the thiol groups of
proteins from oxidation [22]. GSH is also required for regen-
eration of the GPx and glutaredoxin system. Measurement of
GPx activity in lysates of parental cells and stable transfec-
tants by monitoring spectrophotometrically (at 340 nm) the
Fig. 2. E¡ects of Se-W expression and BSO on the sensitivity of
cells to H2O2. A,B: Parental H1299 (A) or CHO dhfr3 (B) cells (tri-
angles) and the corresponding stable transfectants expressing Se-W
(squares) were incubated for the indicated times in the presence of
50 WM (A) or 200 WM (B) H2O2. C,D: Cells were treated as in A
and B, respectively, with the exception that they were preincubated
for 16 h in the presence of 300 WM BSO before exposure to H2O2.
Cell viability was expressed as a percentage of cells excluding trypan
blue in the indicated times, and data are means þ S.D. of values
from ¢ve experiments. *P6 0.05 versus the corresponding value for
parental cells (Student’s t-test).
Fig. 3. E¡ects of Se-W expression and BSO on the intracellular per-
oxide concentration. CHO dhfr3 and CHO dhfr3/selW cells
(2.5U105) in 60-mm dishes were incubated for 24 h before exposure
to 300 WM BSO for 16 h. The cells were then incubated in the ab-
sence or presence of 200 WM H2O2 for 90 min before loading with
20 WM DCFH-DA (Sigma) for 30 min. The cells were washed with
phosphate-bu¡ered saline, detached from the dish by exposure to
trypsin, and ¢xed with 1 ml of phosphate-bu¡ered saline containing
2 mM EDTA, 5 mM dextrose, and 0.1% gelatin [23]. The £uores-
cence of 2P,7P-dichloro£uorescein (DCF) in samples containing
1U104 cells was then determined by £ow cytometry with a FACS-
Calibur instrument (Becton Dickinson). DCF £uorescence, which re-
£ects the intracellular peroxide concentration, was expressed as a
percentage of the value for untreated parental cells. Data are
means þ S.D. of values from three experiments. *P6 0.005,
**P6 0.0001 versus value for untreated parental cells (Student’s
t-test).
Fig. 4. E¡ects of expression of SeC13S or C37S mutants of Se-W
on the sensitivity of cells to H2O2. A: Immunoblot analysis, with a
speci¢c monoclonal antibody (1:1000 dilution) to Se-W, of the
abundance of wild-type and mutant Se-W proteins in lysates of
H1299 and CHO dhfr3 cell transfectants. The puri¢ed SeC13C mu-
tant used as the antigen for preparation of the monoclonal antibody
is shown in the right-most lane. B,C: Parental H1299 (B) and CHO
dhfr3 (C) cells (triangles) and the corresponding stable transfectants
expressing either wild-type Se-W (squares) or the SeC13S (circles) or
C37S (diamonds) mutants were exposed to 50 WM (B) or 200 WM
(C) H2O2 for the indicated times, after which cell viability was ana-
lyzed by trypan blue exclusion. Data are expressed as a percentage
of the value of H2O2-untreated cells and are means þ S.D. of values
from three experiments.
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decrease in NADPH concentration revealed that expression of
Se-W did not a¡ect GPx activity (data not shown).
3.3. GSH-dependent removal of intracellular peroxide by Se-W
Given that stable transfectants were less sensitive to oxida-
tive stress than were parental cells, we next examined the
e¡ect of H2O2 treatment on the intracellular concentration
of ROS. The intracellular peroxide (H2O2) concentration in
CHO dhfr3 cells and CHO dhfr3/selW cells was determined
by £ow cytometry after loading of the cells with the oxidant-
sensitive dye 2P,7P-dichloro£uorescin diacetate (DCFH-DA).
The basal peroxide concentration of the stable transfectants
was lower than that of the parental cells (Fig. 3). Treatment
with H2O2 resulted in an increase in the intracellular peroxide
concentration in the parental cells but not in the stable trans-
fectants. The intracellular peroxide concentrations of both
CHO dhfr3 and CHO dhfr3/selW cells (exposed or not to
H2O2) were increased markedly by pretreatment with BSO.
Similar results were obtained with H1299 and H1299/selW
cells (data not shown). These results thus indicate that Se-W
mediates the removal of H2O2 from cells and that this func-
tion is dependent on GSH.
3.4. Role of SeCys13 and Cys37 in the antioxidant activity of
Se-W
To determine the contributions of SeCys13 and Cys37 to the
antioxidant activity of Se-W, we transfected H1299 and CHO
dhfr3 cells with expression vectors encoding mutant Se-W
proteins in which these residues had been changed individu-
ally to Ser. Expression of the mutant proteins was con¢rmed
by immunoblot analysis of cell lysates with a speci¢c mono-
clonal antibody prepared as described in Section 2 (Fig. 4A).
In contrast to the H2O2 resistance apparent in cells expressing
wild-type Se-W, cells expressing the mutant proteins exhibited
a sensitivity to H2O2 similar to that of parental cells (Fig.
4B,C). These results thus suggest that both SeCys13 and
Cys37 residues are required for the antioxidant function of
Se-W in vivo.
Acknowledgements: We thank T.C. Stadtman (NIH, Bethesda, MD,
USA) for helpful discussion. This work was supported by a grant
(KOSEF 2000-2-20900-008-5) to I.Y.K. from the Korea Science and
Engineering Foundation and by a grant from Korea University.
References
[1] Berlett, B.S. and Stadtman, E.R. (1997) J. Biol. Chem. 272,
20313^20316.
[2] Stadtman, E.R. (1992) Science 257, 1220^1224.
[3] Alsina, B., Corominas, M., Berry, M.J., Baguna, J. and Serras,
F.J. (1999) J. Cell Sci. 112, 2875^2884.
[4] Epp, O., Ladenstein, R. and Wendel, A. (1983) Eur. J. Biochem.
133, 51^69.
[5] Bai, J., Rodriguez, A.M., Melendez, J.A. and Cederbaum, A.I.
(1999) J. Biol. Chem. 274, 26217^26224.
[6] Fridovich, I. (1997) J. Biol. Chem. 272, 18515^18517.
[7] Prinz, W.A., Aslund, F., Holmgren, A. and Beckwith, J. (1997)
J. Biol. Chem. 272, 15661^15667.
[8] Saito, Y., Hayashi, T., Tanaka, A., Watanabe, Y., Suzuki, M.,
Saito, E. and Takahashi, K. (1999) J. Biol. Chem. 274, 2866^
2871.
[9] Beilstein, M.A., Vendeland, S.C., Barofsky, E., Jensen, O.N. and
Whanger, P.D. (1996) J. Inorg. Biochem. 61, 117^124.
[10] Gu, Q.P., Beilstein, M.A., Barofsky, E., Ream, W. and Whanger,
P.D. (1999) Arch. Biochem. Biophys. 361, 25^33.
[11] Vendeland, S.C., Beilstein, M.A., Chen, C.L., Jensen, O.N.,
Barofsky, E. and Whanger, P.D. (1993) J. Biol. Chem. 268,
17103^17107.
[12] Yeh, J.Y., Beilstein, M.A., Andrews, J.S. and Whanger, P.D.
(1995) FASEB J. 9, 392^396.
[13] Yeh, J.Y., Gu, Q.P., Beilstein, M.A., Forsberg, N.E. and Whan-
ger, P.D. (1997) J. Nutr. 127, 394^402.
[14] Yeh, J.Y., Vendeland, S.C., Gu, Q., Butler, J.A., Ou, B.R. and
Whanger, P.D. (1997) J. Nutr. 127, 2165^2172.
[15] Allan, C.B., Lacourciere, G.M. and Stadtman, T.C. (1999) Annu.
Rev. Nutr. 19, 1^16.
[16] Sun, Y., Gu, Q.P. and Whanger, P.D. (1998) FASEB J. 12, A824
(abstract).
[17] Stadtman, T.C. (1975) in: Advances in Enzymology and Related
Areas of Molecular Biology, Vol. 48 (Meister, A., Ed.), pp. 1^27,
John Wiley and Sons, New York.
[18] Anderson, M. (1985) Methods Enzymol. 113, 548^555.
[19] Yamamoto, H., Satoh, T., Kiyohara, T., Totsuka, A. and
Moritsugu, Y. (1997) Biologicals 25, 373^380.
[20] Chen, K.H., Reece, L.M. and Leary, J.F. (1999) Free Radic.
Biol. Med. 27, 100^109.
[21] E¡erth, T., Fabry, U., Glatte, P. and Osieka, R. (1995) J. Mol.
Med. 73, 47^49.
[22] Lu, S.C. (1999) FASEB J. 13, 1169^1183.
[23] Robinson, J.P. (1994) Methods Cell Biol. 41, 437^441.
FEBS 26018 12-4-02
D.-w. Jeong et al./FEBS Letters 517 (2002) 225^228228
